Signature of the Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance

January 1, 2016
BEAM Alliance, BEAM Alliance

January 2016. Signature of the Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance. The BEAM Alliance signed the Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance that was launched on January 21, 2016. The declaration calls upon governments to work with global pharmaceutical, diagnostics and biotechnology industries to develop new ways to provide sustainable market models for antibiotics and commit the funds needed to implement them. The BEAM Alliance and the other signatories commit themselves to further action in reducing the development of drug resistance, increasing investment in R&D to meet public health needs and to improve access to high-quality antibiotics for all. Learn more here.